Revised International Prognostic Scoring System for Myelodysplastic Syndromes

Impact of Age and Comorbidity in Myelodysplastic Syndromes

(2017) Reinhard Stauder et al.   Journal of the National Comprehensive Cancer Network

Myelodysplastic Syndromes

(2017) Peter L. Greenberg et al.   Journal of the National Comprehensive Cancer Network

New Comprehensive Cytogenetic Scoring System for Primary Myelodysplastic Syndromes (MDS) and Oligoblastic Acute Myeloid Leukemia After MDS Derived From an International Database Merge

(2012) Julie Schanz et al.   JOURNAL OF CLINICAL ONCOLOGY

Standardization of flow cytometry in myelodysplastic syndromes: a report from an international consortium and the European LeukemiaNet Working Group

(2012) T M Westers et al.   LEUKEMIA

Clonal Architecture of Secondary Acute Myeloid Leukemia

(2012) Matthew J. Walter et al.   NEW ENGLAND JOURNAL OF MEDICINE

Prognostic impact of severe thrombocytopenia in low-risk myelodysplastic syndrome

(2011) Jose Ramon Gonzalez-Porras et al.   CANCER

Impact of the degree of anemia on the outcome of patients with myelodysplastic syndrome and its integration into the WHO classification-based Prognostic Scoring System (WPSS)

(2011) L. Malcovati et al.   HAEMATOLOGICA

Association of Comorbidities With Overall Survival in Myelodysplastic Syndrome: Development of a Prognostic Model

(2011) Kiran Naqvi et al.   JOURNAL OF CLINICAL ONCOLOGY

Ferritin level at diagnosis is not correlated with poorer survival in non RBC transfusion dependent lower risk de novo MDS

(2011) S. Park et al.   LEUKEMIA RESEARCH

The degree of neutropenia has a prognostic impact in low risk myelodysplastic syndrome

(2011) I. Cordoba et al.   LEUKEMIA RESEARCH

Time changes in predictive power of established and recently proposed clinical, cytogenetical and comorbidity scores for Myelodysplastic Syndromes

(2011) Michael Pfeilstöcker et al.   LEUKEMIA RESEARCH

SomaticSF3B1Mutation in Myelodysplasia with Ring Sideroblasts

(2011) E. Papaemmanuil et al.   NEW ENGLAND JOURNAL OF MEDICINE

Clinical Effect of Point Mutations in Myelodysplastic Syndromes

(2011) Rafael Bejar et al.   NEW ENGLAND JOURNAL OF MEDICINE

Risk stratification based on both disease status and extra-hematologic comorbidities in patients with myelodysplastic syndrome

(2010) M. G. Della Porta et al.   HAEMATOLOGICA

Prognostic impact of age and gender in 897 untreated patients with primary myelodysplastic syndromes

(2009) T. Nösslinger et al.   ANNALS OF ONCOLOGY

Comorbidity as prognostic variable in MDS: comparative evaluation of the HCT-CI and CCI in a core dataset of 419 patients of the Austrian MDS Study Group

(2009) W. R. Sperr et al.   ANNALS OF ONCOLOGY

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

(2009) J. W. Vardiman et al.   BLOOD

The hematopoietic stem cell transplantation comorbidity index is of prognostic relevance for patients with myelodysplastic syndrome

(2009) E. Zipperer et al.   HAEMATOLOGICA

Comorbidities and survival in a large cohort of patients with newly diagnosed myelodysplastic syndromes

(2009) Rong Wang et al.   LEUKEMIA RESEARCH

International MDS risk analysis workshop (IMRAW)/IPSS reanalyzed: Impact of cytopenias on clinical outcomes in myelodysplastic syndromes

(2008) Jelena M. Kao et al.   AMERICAN JOURNAL OF HEMATOLOGY

Prognostic significance of serial determinations of lactate dehydrogenase (LDH) in the follow-up of patients with myelodysplastic syndromes

(2008) F. Wimazal et al.   ANNALS OF ONCOLOGY

Proposal for a new risk model in myelodysplastic syndrome that accounts for events not considered in the original International Prognostic Scoring System

(2008) Hagop Kantarjian et al.   CANCER

Clinical Relevance of Bone Marrow Fibrosis and CD34-Positive Cell Clusters in Primary Myelodysplastic Syndromes

(2008) Matteo Giovanni Della Porta et al.   JOURNAL OF CLINICAL ONCOLOGY

Levels of beta 2 microglobulin have a prognostic relevance for patients with myelodysplastic syndrome with regard to survival and the risk of transformation into acute myelogenous leukemia

(2008) Frank Neumann et al.   LEUKEMIA RESEARCH